Earlier Detection Could Mean Earlier Treatment for Patients with Parkinson’s Disease

Parkinson’s disease is a progressive neurodegenerative disease that affects dopamine-producing neurons in the brain. The disease is characterized by a progressive loss of muscle control leading to bradykinesia (slow movement), rigidity, resting tremor, and postural instability.  As symptoms worsen, it may be difficult to walk, talk, and perform simple tasks. Non-motor symptoms can include; anxiety, depression, psychosis, and dementia.

Read more

By the Year 2030 1.2 Million Americans May be Living with Parkinson’s Disease

Parkinson’s disease is a degenerative disorder of the central nervous system characterized by a progressive loss of muscle control leading to slow movements (bradykinesia), rigidity, resting tremor and postural instability. As symptoms worsen it may be difficult to walk, talk, and perform simple daily tasks. Non-motor symptoms can include; anxiety, depression, psychosis and dementia.

Read more

April is Parkinson’s Awareness Month: Large study shows concussions lead to increased risk of developing Parkinson’s disease.

The results of a study evaluating more than 300,000 U.S. military veterans showed even a mild a concussion resulting in a loss of consciousness increases the risk of Parkinson’s disease.  Mild traumatic brain injuries (TBIs), commonly referred to as concussions, led to a 56% increased risk of developing Parkinson’s disease. The study also showed that when the brain trauma was more severe, the risk of developing Parkinson’s was even higher; for those participants that suffered from a moderate or severe brain injury the increased risk was 83%.

Read more

April is Parkinson’s Awareness Month

CNN reports at least 700 patients have died after using Parkinson’s drug to treat disease related psychosis

On April 9, CNN reported hundreds of patients have died while taking the drug Nuplazid, a drug meant to control Parkinson’s disease psychosis. According to the CNN story, hundreds of patients have died while a significant number of other patients are not receiving any benefit from the drug.

Read more

April is Parkinson’s Awareness Month: 11 facts you need to know about Parkinson’s disease

Parkinson’s disease is a neurodegenerative disease characterized by a progressive loss of muscle control leading to bradykinesia (slow movement), rigidity, resting tremor and postural instability.  As symptoms worsen, it may be difficult to walk, talk, and perform simple tasks. Non-motor symptoms can include; anxiety, depression, psychosis, and dementia.

Dopamine is a chemical that acts as a messenger between brain cells. It plays a role in how we move, what we eat, and how we learn. The substantia nigra, a tiny strip of tissue on both sides of the base of your brain produces dopamine. When the brain cells in the substantia nigra start to die, dopamine levels drop. When the level of dopamine gets to low, you will begin to experience symptoms of Parkinson’s disease.

Read more